← FDA Drug Approvals (Drugs@FDA)
CIPROFLOXACIN AND DEXAMETHASONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-10-15
Drug application
- FDA Application #
ANDA217723- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CIPROFLOXACIN AND DEXAMETHASONE
- Generic name
- Ciprofloxacin
- Active ingredients
- CIPROFLOXACIN; DEXAMETHASONE
- Dosage form
- SUSPENSION/DROPS
- Route
- OTIC
- Marketing status
- Prescription
- Sponsor
- ALEMBIC
- First approval
- 2026-10-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown